Cancer Research AACR Conference on Molecular Diagnostics - 2008  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugita, M.
Right arrow Articles by Franklin, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugita, M.
Right arrow Articles by Franklin, W. A.
[Cancer Research 62, 3971-3979, July 15, 2002]
© 2002 American Association for Cancer Research


Clinical Investigations

Combined Use of Oligonucleotide and Tissue Microarrays Identifies Cancer/Testis Antigens as Biomarkers in Lung Carcinoma1

Michio Sugita, Mark Geraci, Bifeng Gao, Roger L. Powell, Fred R. Hirsch, Gary Johnson, Razvan Lapadat, Edward Gabrielson, Roy Bremnes, Paul A. Bunn and Wilbur A. Franklin2

Departments of Pathology [M. S., R. L. P., W. A. F.], Medicine [M. G., B. G., F. R. H., R. B., P. A. B.], and Pharmacology[G. J., R. L.], University of Colorado Health Sciences Center, Denver, Colorado 80262, and Department of Pathology, F. S. Key Medical Center, Baltimore, Maryland 21224 [E. G.]

High density oligonucleotide microarrays (OMAs) have been used recently to profile gene expression in lung carcinoma tissue homogenates. The length of the lists of potentially interesting genes generated by these studies is daunting, and biological and clinical relevance of these lists remains to be validated. Moreover, specific identification of individual biomarkers that might be used for early detection and surveillance has not been the objective of these early studies. We have developed a schema for combining the data derived from the OMA analysis of a few lung cancer cell lines with immunohistochemical testing of tissue microarrays to rapidly identify biomarkers of potential clinical relevance. Initially, we profiled gene expression in lung tumor cell lines using the Affymetrix HG-U95Av2 OMA. RNA from 2 non-small cell lung cancer (NSCLC) cell lines (A549 and H647) and 2 small cell lung cancer (SCLC) cell lines (SHP-77 and UMC-19) were tested. Cells from 1 histologically and cytogenetically normal bronchial epithelial primary culture from a volunteer who had never smoked and 10 samples of histologically unremarkable lung tissue from resection specimens served as normalization controls. Array results were analyzed with Gene Spring software. Results were confirmed by reverse transcription-PCR in an expanded number of cell lines. We then validated the cell line data by immunohistochemical testing for protein using a tissue microarray containing 187 NSCLC clinical samples. Of the 20 most highly expressed genes in the tumor lines, 6 were members of the cancer/testis antigen (CTAG) gene group including 5 MAGE-A subfamily members and NY-ESO-1. SCLC lines strongly expressed all of the MAGE-A genes as well as NY-ESO-1, whereas NSCLC lines expressed a subset of MAGE-A genes at a lower level of intensity and failed to express NY-ESO-1. Reverse transcription-PCR of an extended series of 25 lung cancer cell lines including 13 SCLC, 9 NSCLC, and 3 mesothelioma lines indicated that MAGE-A10 and NY-ESO-1 were expressed only by SCLC, and that MAGE-A1, 3, 6, 12, and 4b were expressed by both SCLC and NSCLC. By immunohistochemistry using the monoclonal antibody 6C1 that recognizes several MAGE-A gene subfamily members, 44% of NSCLC clearly expressed MAGE-A proteins in cytoplasm and/or nucleus. Expression of MAGE-A genes did not correlate with survival but did correlate with histological classification with squamous carcinomas more frequently MAGE-A positive than other NSCLC types (P < 0.00002). We conclude that expression of CTAG gene products, whereas apparently not of prognostic importance, may be useful for early detection and surveillance because of a high level of specificity for central airway squamous and small cell carcinomas.




This article has been cited by other articles:


Home page
FASEB J.Home page
S. Sakao, L. Taraseviciene-Stewart, C. D. Cool, Y. Tada, Y. Kasahara, K. Kurosu, N. Tanabe, Y. Takiguchi, K. Tatsumi, T. Kuriyama, et al.
VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+ precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells
FASEB J, November 1, 2007; 21(13): 3640 - 3652.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson
The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1087 - 1097.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. N. Hayes, S. Monti, G. Parmigiani, C. B. Gilks, K. Naoki, A. Bhattacharjee, M. A. Socinski, C. Perou, and M. Meyerson
Gene Expression Profiling Reveals Reproducible Human Lung Adenocarcinoma Subtypes in Multiple Independent Patient Cohorts
J. Clin. Oncol., November 1, 2006; 24(31): 5079 - 5090.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Peikert, U. Specks, C. Farver, S. C. Erzurum, and S. A.A. Comhair
Melanoma Antigen A4 Is Expressed in Non-Small Cell Lung Cancers and Promotes Apoptosis.
Cancer Res., May 1, 2006; 66(9): 4693 - 4700.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. S. Stearman, L. Dwyer-Nield, L. Zerbe, S. A. Blaine, Z. Chan, P. A. Bunn Jr., G. L. Johnson, F. R. Hirsch, D. T. Merrick, W. A. Franklin, et al.
Analysis of Orthologous Gene Expression between Human Pulmonary Adenocarcinoma and a Carcinogen-Induced Murine Model
Am. J. Pathol., December 1, 2005; 167(6): 1763 - 1775.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. O. Gure, R. Chua, B. Williamson, M. Gonen, C. A. Ferrera, S. Gnjatic, G. Ritter, A. J.G. Simpson, Y.-T. Chen, L. J. Old, et al.
Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non-Small Cell Lung Cancer
Clin. Cancer Res., November 15, 2005; 11(22): 8055 - 8062.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
Y. WANG, J. HAYAKAWA, F. LONG, Q. YU, A. H. CHO, G. RONDEAU, J. WELSH, S. MITTAL, I. DE BELLE, E. ADAMSON, et al.
"Promoter Array" Studies Identify Cohorts of Genes Directly Regulated by Methylation, Copy Number Change, or Transcription Factor Binding in Human Cancer Cells
Ann. N.Y. Acad. Sci., November 1, 2005; 1058(1): 162 - 185.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. E. Miller
Pathogenesis of Lung Cancer: 100 Year Report
Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 216 - 223.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Gnjatic
Immunogenic Targets in Non-Small Cell Lung Cancer: More Is More
Clin. Cancer Res., August 1, 2005; 11(15): 5331 - 5332.
[Full Text] [PDF]


Home page
JCOHome page
M. Meyerson and D. Carbone
Genomic and Proteomic Profiling of Lung Cancers: Lung Cancer Classification in the Age of Targeted Therapy
J. Clin. Oncol., May 10, 2005; 23(14): 3219 - 3226.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. T. Cheung, K. L. Leung, Y. C. Ip, X. Chen, D. Y. Fong, I. O. Ng, S. T. Fan, and S. So
Claudin-10 Expression Level is Associated with Recurrence of Primary Hepatocellular Carcinoma
Clin. Cancer Res., January 15, 2005; 11(2): 551 - 556.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. I. Dumur, S. Nasim, A. M. Best, K. J. Archer, A. C. Ladd, V. R. Mas, D. S. Wilkinson, C. T. Garrett, and A. Ferreira-Gonzalez
Evaluation of Quality-Control Criteria for Microarray Gene Expression Analysis
Clin. Chem., November 1, 2004; 50(11): 1994 - 2002.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. D. Hoang, X. Zhang, P. D. Scott, T. J. Guillaume, M. A. Maddaus, D. Yee, and R. A. Kratzke
Selective Activation of Insulin Receptor Substrate-1 and -2 in Pleural Mesothelioma Cells: Association with Distinct Malignant Phenotypes
Cancer Res., October 15, 2004; 64(20): 7479 - 7485.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. A. Whitsett, C. J. Bachurski, K. C. Barnes, P. A. Bunn Jr., L. M. Case, D. N. Cook, D. Crooks, M. W. Duncan, L. Dwyer-Nield, R. C. Elston, et al.
Functional Genomics of Lung Disease
Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2/S1): S1 - S81.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. C. Borczuk, L. Shah, G. D. N. Pearson, K. L. Walter, L. Wang, J. H. M. Austin, R. A. Friedman, and C. A. Powell
Molecular Signatures in Biopsy Specimens of Lung Cancer
Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 167 - 174.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
T. Koga, Y. Horio, T. Mitsudomi, T. Takahashi, and Y. Yatabe
Identification of MGB1 as a Marker in the Differential Diagnosis of Lung Tumors in Patients with a History of Breast Cancer by Analysis of Publicly Available SAGE Data
J. Mol. Diagn., May 1, 2004; 6(2): 90 - 95.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. D. Hoang, J. D'Cunha, S. H. Tawfic, A. C. Gruessner, R. A. Kratzke, and M. A. Maddaus
Expression profiling of non-small cell lung carcinoma identifies metastatic genotypes based on lymph node tumor burden
J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1332 - 1342.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. D. Hoang, J. D'Cunha, M. G. Kratzke, C. E. Casmey, S. P. Frizelle, M. A. Maddaus, and R. A. Kratzke
Gene Expression Profiling Identifies Matriptase Overexpression in Malignant Mesothelioma
Chest, May 1, 2004; 125(5): 1843 - 1852.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W. A. Franklin
Premalignant Evolution of Lung Cancer: Gilles F. Filley Lecture
Chest, May 1, 2004; 125(5_suppl): 90S - 94S.
[Full Text] [PDF]


Home page
ChestHome page
N. Kaminski and M. Krupsky
Gene Expression Patterns, Prognostic and Diagnostic Markers, and Lung Cancer Biology
Chest, May 1, 2004; 125(5_suppl): 111S - 115S.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. Zhou, Y. You, J. Zabner, A. J. Ryan, and R. K. Mallampalli
The CCT Promoter Directs High-Level Transgene Expression in Distal Lung Epithelial Cell Lines
Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 61 - 68.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
I. B. Copland, B. P. Kavanagh, D. Engelberts, C. McKerlie, J. Belik, and M. Post
Early Changes in Lung Gene Expression due to High Tidal Volume
Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1051 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
J. C. Sok, M. A. Kuriakose, V. B. Mahajan, A. N. Pearlman, M. D. DeLacure, and F.-A. Chen
Tissue-Specific Gene Expression of Head and Neck Squamous Cell Carcinoma In Vivo by Complementary DNA Microarray Analysis
Arch Otolaryngol Head Neck Surg, July 1, 2003; 129(7): 760 - 770.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
Y. Hoshikawa, P. Nana-Sinkam, M. D. Moore, S. Sotto-Santiago, T. Phang, R. L. Keith, K. G. Morris, T. Kondo, R. M. Tuder, N. F. Voelkel, et al.
Hypoxia induces different genes in the lungs of rats compared with mice
Physiol Genomics, February 6, 2003; 12(3): 209 - 219.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.